Literature DB >> 16187703

[Risk factors for surgical site infections in newborns in a neonatal intensive care unit].

Heladia J García1, Xóchitl Rodríguez-Medina, Mario Franco-Gutiérrez, Guadalupe Miranda-Novales, Raúl Villegas-Silva.   

Abstract

OBJECTIVE: To identify risk factors associated to surgical site infection (SSI) in newborns.
DESIGN: Case-control study. Site. Neonatal intensive care unit (NICU), Hospital de Pediatría, Centro Medico Nacional SXXI, IMSS. PATIENTS: 279 patients were included (125 cases and 154 controls). DATA: Gestational age, birth weight, previous infection, hospital stay, type of surgery, surgical drains, length of surgical procedure, bleeding during surgery, surgical site classification, serum albumin, classification of infection and surgeon performing the procedure.
RESULTS: Five independent factors associated to SSI were identified: surgical reinterventions (OR = 13.6, CI 95% = 4.3-42.7); length of surgery > 60 minutes (OR = 3.0, CI 95% = 1.4-6.3); preoperative stay > 5 days (OR = 2.8, CI 95% = 1.3-5.6); consultant surgeon (OR = 2.7, CI 95% = 1.3-5.3), and previous systemic infection (OR = 2.1, CI 95% = 1.1-4.3). Lethality was 8.2% (n = 23), 74% in the group of cases (n = 17).
CONCLUSIONS: Factors associated to SSI are mainly related to the characteristics of surgery and those of the patient. Lethality was low, but most of deaths were in the group of cases.

Entities:  

Mesh:

Year:  2005        PMID: 16187703

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  2 in total

1.  Surgical site infections in neonates are independently associated with longer hospitalizations.

Authors:  E A Gilje; M J Hossain; C D Vinocur; L Berman
Journal:  J Perinatol       Date:  2017-07-27       Impact factor: 2.521

2.  Surgical site infections in infants admitted to the neonatal intensive care unit.

Authors:  Ilan Segal; Christine Kang; Susan G Albersheim; Erik D Skarsgard; Pascal M Lavoie
Journal:  J Pediatr Surg       Date:  2014-03       Impact factor: 2.545

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.